Biomerica BMRA
NASDAQ BMRA
$1.59 +0.07 (+4.26%)
As of: Aug 20, 2026 · 3:04 PM EDT

Biomerica (BMRA) Debt Ratio (2011 - 2012)

Biomerica (BMRA) posted Debt Ratio of 0.01 for Q2 2012, up 233.59% sequentially from 0.0 in Q4 2011, and up 8.08% YoY from 0.01 in Q2 2011.

Biomerica (BMRA) Debt Ratio (2011 - 2012) Analysis & Trends

Biomerica has reported Debt Ratio for 2 years, with the latest figure at 0.01 in Q2 2012.

  • Quarterly Debt Ratio rose 8.08% year-over-year to 0.01 in Q2 2012, while the trailing twelve-month figure through May 2012 was 0.01 (up 8.08% YoY) and the FY2012 annual result came in at 0.01, up 8.08% from the prior year.
  • Debt Ratio improved to 0.01 in Q2 2012 per BMRA's latest filing, from 0.0 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.01 in Q2 2012 and troughed at 0.0 in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 0.30
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 0.31
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 0.30
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 0.28
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 0.04
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 0.27
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 0.28
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 0.18
10 Biomerica 4.77 Mn 3.44 Mn -44,000.00 -

Historic Data

Download Data
DateValue
May 31, 2012 0.01
Nov 30, 2011 0.00
Aug 31, 2011 0.00
May 31, 2011 0.01